METiS Therapeutics is using AI to facilitate drug discovery to revolutionize therapies for patients with serious diseases. To improve therapies, METiS is creating a robust and targeted delivery system for small molecules, RNA and gene therapies. Using AI and high-throughput in vivo screening, METiS has made most progress with discovering unique lipid nanoparticles (LNPs) with world class capabilities. These LNPs can target multiple organ systems with in vivo evidence of high delivery efficiency and clean safety profiles. To progress their technologies, METiS is actively partnering with other biotechnology companies.

METiS Therapeutics

Founded: 2019
Location: Cambridge, MA
Employee range: 1 - 10
Funding: $86M A Dec 2021

Short description:

Drug notes:

Long description:

Jobs: